Skip to main content
Caplight Logo









VC Cell Therapy

VC Cell Therapy

Private
KobeHealthcare & Life Scienceshttps://www.vcct.jp/

Last Round

VC Round

Nov 15, 2023

Total Funding Raised

$7.33M

Company Overview

VC Cell Therapy is a biotechnology company that develops regenerative cell therapies for retinal degeneration diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B2C

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Infrastructure

Keywords

cell therapyinduced pluripotent stem cellsiPSCsregenerative medicineretinal degenerationallogeneic cell therapyoff-the-shelf cell therapyRPE cellsphotoreceptor cellsAge-related Macular DegenerationAMDRetinitis PigmentosaRPretinal organoidsautomated cell manufacturinggenome editingAI in manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VC Cell Therapy Comparables

Compare VC Cell Therapy with similar companies based on industry and business-model similarity.

VC Cell Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Regenerative Patch Technologies
79%
Eyestem Research
78%
jCyte, Inc.
76%

VC Cell Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 15, 2023
Convertible DebtApr 1, 2021

VC Cell Therapy Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2023

    $4M raised from YASKAWA Electric Corporation and others.

  • Apr 1, 2021

    Raised $5.33M in convertible debt.

VC Cell Therapy Filings

Explore SEC and related filing metadata, where available.

VC Cell Therapy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VC Cell Therapy's valuation, stock price, and market status.

Is VC Cell Therapy a public or private company?

VC Cell Therapy is a private company.

What is the current stock price of VC Cell Therapy?

VC Cell Therapy is a private company with no public stock price. No recent secondary market data is available.

How much is VC Cell Therapy worth (valuation)?

Valuation information for VC Cell Therapy is not publicly available.

Can I buy VC Cell Therapy stock?

VC Cell Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VC Cell Therapy's last funding round?

VC Cell Therapy's most recent funding round was VC Round on November 15, 2023.

Who are the main investors in VC Cell Therapy?

Key investors in VC Cell Therapy include 株式会社日本政策金融公庫, プラスソーシャルインベストメント株式会社.

Will VC Cell Therapy IPO soon?

No public IPO plans have been announced for VC Cell Therapy.

How can I track VC Cell Therapy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VC Cell Therapy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKobe
Employee Range3
Year Founded2021
Last FundingNov 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?